60 studies found for:    BUTYRYLCHOLINESTERASE
Show Display Options
RSS Create an RSS feed from your search for:
BUTYRYLCHOLINESTERASE
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Study to Investigate the Safety and Tolerability of AZD8848 in Butyrylcholinesterase Deficient Subjects
Condition: Butyrylcholinesterase Deficiency
Intervention: Drug: AZD8848
2 Not yet recruiting Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine
3 Not yet recruiting Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Rivastigmine
4 Completed Impact of Cholinesterase Inhibitors on Driving Ability in Healthy Older Adults
Conditions: Mental Health;   Geriatrics
Interventions: Drug: donepezil;   Drug: Placebo (cornstarch)
5 Completed A Study of Plasma-Derived Human Butyrylcholinesterase Administered Intramuscularly
Condition: Healthy
Interventions: Drug: Human butyrylcholinesterase (HuBChE) derived from human plasma;   Drug: Placebo: Normal saline
6 Completed Pharmacokinetic (PK) and Safety Study of Plasma-derived Human Butyrylcholinesterase Administered Intravenously
Conditions: Chemical Terrorism;   Chemical Warfare
Interventions: Drug: Human Butyrylcholinesterase (HuBChE) derived from human plasma;   Drug: Placebo: Normal saline
7 Recruiting Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease
Conditions: Alzheimer's Disease;   Dementia
Interventions: Drug: Cholinesterase Inhibitor;   Drug: Placebo
8 Recruiting Relevance of the Peripheral Cholinesterase-activity on Neurocognitive Dysfunctions in Surgical Patients
Condition: Postoperative Delirium
Intervention:
9 Completed Estimation of Functional Liver Reserve Using Cholinesterases
Conditions: Hepatocellular Carcinoma;   Cirrhosis;   Liver Neoplasm;   Liver Disease
Intervention:
10 Completed Good Rate of Clinical Response to Cholinesterase Inhibitors in Alzheimer's Disease After Three Months of Treatment
Condition: Late Onset Alzheimer
Intervention:
11 Completed The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia
Condition: Alzheimer Disease, Late Onset
Intervention: Drug: cholinesterase inhibitors
12 Completed Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase Inhibitors
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine transdermal patch
13 Recruiting A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease
Condition: Lewy Body Disease
Intervention: Drug: Cholinesterase Inhibitors (Rivastigmine, Aricept, Galantamine)
14 Completed Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: lecozotan SR (SRA-333)
15 Completed To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.
Condition: Alzheimer's Disease
Intervention: Drug: Atorvastatin
16 Recruiting Bisnorcymserine in Healthy Adult Volunteers
Condition: Alzheimer's Disease
Intervention: Drug: BNC
17 Recruiting Effect of Galantamine on Short-term Abstinence
Conditions: Treatment-seeking Smokers, Reporting Consumption of at Least 10 Cigarettes;   Per Day for at Least the Past 6 Months
Intervention: Drug: Galantamine Hydrobromide-ER
18 Recruiting Effect of Galantamine on Short-term Abstinence
Condition: Tobacco Use Disorder
Interventions: Drug: Galantamine;   Drug: Placebo
19 Completed Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment
Condition: Alzheimer's Disease
Intervention: Drug: Rivastigmine, memantine
20 Recruiting Treatment of Residual Amblyopia With Donepezil
Condition: Amblyopia
Interventions: Drug: Donepezil;   Other: Patching

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years